We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
80 hedge funds and large institutions have $301M invested in Revance Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 19 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
111% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 19
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less funds holding
Funds holding: 98 → 80 (-18)
46% less capital invested
Capital invested by funds: $556M → $301M (-$255M)
67% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 27
Holders
80
Holders Change
-18
Holders Change %
-18.37%
% of All Funds
2.32%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
40
Reduced
19
Closed
27
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
+$27.1M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$7.01M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$3.98M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$3.69M |
| 5 |
JP Morgan Chase
New York
|
+$3M |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$21.4M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$21.4M |
| 3 |
VAM
Visium Asset Management
New York
|
-$12.3M |
| 4 |
DM
Deerfield Management
New York
|
-$8.72M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$5.02M |
